1. Home
  2. Stocks
  3. Metropolis Share Price

Metropolis Healthcare Share Price

Healthcare Mid Cap

₹2,149.15 +45.2 (2.15%)

05 Nov, 2024 21:55

SIP TrendupStart SIP in METROPOLIS

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹2,089
  • High
  • ₹2,154
  • 52 Week Low
  • ₹1,450
  • 52 Week High
  • ₹2,318
  • Open Price₹2,091
  • Previous Close₹2,104
  • Volume183,303

Investment Returns

  • Over 1 Month -3.83%
  • Over 3 Month + 3.13%
  • Over 6 Month + 20.04%
  • Over 1 Year + 45.96%
SIP Lightning

Smart Investing Starts Here Start SIP with Metropolis Healthcare for Steady Growth!

Metropolis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 80.4
  • PEG Ratio
  • -84.7
  • Market Cap Cr
  • 11,018
  • P/B Ratio
  • 10
  • Average True Range
  • 61.47
  • EPS
  • 22.5
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -10.18
  • RSI
  • 47.82
  • MFI
  • 37.96

Metropolis Healthcare Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations286.14292.27269.41285.46256.29
Total Income From Operations286.14292.27269.41285.46256.29
P/L Before Interest, Excpt. Items & Tax46.3450.7039.8848.1141.06
P/L Before Exceptional Items & Tax41.7245.0534.6342.4935.23
P/L After Tax from Ordinary Activities31.2831.7826.7031.2826.13
Net Profit/Loss For the Period31.2831.7826.7031.2826.13
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,103.431,066.04
Revenue From Operations [Net]1,103.431,066.04
Total Operating Revenues1,103.431,066.04
Total Revenue1,115.421,087.32
Total Expenses958.01908.38
Profit/Loss Before Tax157.41178.95
Profit/Loss For The Period115.89138.95
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity269.01237.74
Net Cash Used In Investing Activity-81.0046.72
Net Cash Used in Finance Activity-183.00-287.87
Net Inc/Dec In Cash And Equivalent4.50-3.40
Cash And Equivalent End Of Year28.5924.09
IndicatorMar 24Mar 23
Total Share Capital10.2510.24
Total Non-Current Liabilities207.14245.01
Total Current Liabilities234.37253.27
Total Capital And Liabilities1,472.701,434.29
Total Non-Current Assets1,200.261,168.86
Total Current Assets272.44265.44
Total Assets1,472.701,434.29
Indicator20242023
EBIT Margin (%)16.2819.28
Return On Capital Employed (%)14.5117.41
Return On Equity (%)11.2314.84
Long Term Debt To Equity (%)0.003.28
Book Value/Share (INR)201.30182.78
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations313.36331.00291.12308.50277.09
Total Income From Operations313.36331.00291.12308.50277.09
P/L Before Interest, Excpt. Items & Tax55.7356.1042.1653.7945.17
P/L Before Exceptional Items & Tax51.0850.5336.8548.1139.19
P/L After Tax from Ordinary Activities38.1136.5327.2935.6628.98
Net Profit/Loss For the Period38.1136.5327.2935.6628.98
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,207.711,148.21
Revenue From Operations [Net]1,207.711,148.21
Total Operating Revenues1,207.711,148.21
Total Revenue1,216.831,163.43
Total Expenses1,042.14975.93
Profit/Loss Before Tax174.69187.50
Profit/Loss For The Period128.46143.39
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity264.07247.09
Net Cash Used In Investing Activity-89.4146.79
Net Cash Used in Finance Activity-181.20-292.33
Net Inc/Dec In Cash And Equivalent-6.212.85
Cash And Equivalent End Of Year62.6268.83
IndicatorMar 24Mar 23
Total Share Capital10.2510.24
Total Non-Current Liabilities209.91245.93
Total Current Liabilities245.87264.97
Total Capital And Liabilities1,555.061,501.61
Total Non-Current Assets1,239.231,198.87
Total Current Assets315.83302.73
Total Assets1,555.061,501.61
Indicator20242023
EBIT Margin (%)16.3318.66
Return On Capital Employed (%)15.0617.32
Return On Equity (%)11.6614.45
Long Term Debt To Equity (%)0.002.89
Book Value/Share (INR)214.59193.46

Metropolis Healthcare Technicals

EMA & SMA

Current Price
₹2,149.15
+ 45.2 (2.15%)
pointer
  • stock-down_img
  • Bullish Moving Average 10
  • stock-up_img
  • Bearish Moving Average 6
  • 20 Day
  • ₹2,159.78
  • 50 Day
  • ₹2,152.78
  • 100 Day
  • ₹2,090.05
  • 200 Day
  • ₹1,960.38

Resistance and Support

2130.8 Pivot Speed
  • R3 2,236.50
  • R2 2,195.15
  • R1 2,172.15
  • S1 2,107.80
  • S2 2,066.45
  • S3 2,043.45

Is Metropolis Healthcare Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Metropolis Healthcare Ltd. is a leading diagnostic service provider in India, offering a wide range of pathology tests and healthcare solutions. With an extensive network of labs and collection centers, it serves patients across India and international markets. Metropolis Healthcare has an operating revenue of Rs. 1,243.97 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 57 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 29 indicates it belongs to a strong industry group of Medical-Services and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Metropolis Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-08-10 Quarterly Results
2024-05-21 Audited Results
2024-02-02 Quarterly Results
2023-11-04 Quarterly Results & Interim Dividend
Date Purpose Remarks
2023-11-17 INTERIM Rs.4.00 per share(200%)Interim Dividend
2023-02-23 INTERIM Rs.8.00 per share(400%)Interim Dividend (Revised)
2022-02-22 INTERIM Rs.8.00 per share(400%)Interim Dividend
2021-02-19 INTERIM Rs.8.00 per share(400%)Interim Dividend

Metropolis Healthcare F&O

Metropolis Healthcare Shareholding Pattern

49.43%
24.33%
3.56%
18.56%
3.54%
0.58%
  • NSE Symbol
  • METROPOLIS
  • BSE Symbol
  • 542650
  • Managing Director
  • Mrs. Ameera Sushil Shah
  • ISIN
  • INE112L01020

Metropolis Healthcare FAQs

Metropolis Healthcare share price is ₹2,149 As on 05 November, 2024 | 21:41

The Market Cap of Metropolis Healthcare is ₹11018.1 Cr As on 05 November, 2024 | 21:41

The P/E ratio of Metropolis Healthcare is 80.4 As on 05 November, 2024 | 21:41

The PB ratio of Metropolis Healthcare is 10 As on 05 November, 2024 | 21:41

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.